Regional differences in early stage bladder cancer care and outcomes

Urology

Volumn 76, Issue 2, 2010, Pages 391-396

  Skolarus, Ted A ^a   Ye, Zaojun ^a   Zhang, Sean ^a   Hollenbeck, Brent K ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLADDER CANCER; CANCER STAGING; CANCER SURVIVAL; FEMALE; HOSPITAL SERVICE; HUMAN; MALE; MEDICARE; PATIENT CARE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; NEOPLASM STAGING; TREATMENT OUTCOME; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 77955712399     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.12.079     Document Type: Article

References (37)

1. C. Snyder, L. Harlan, K. Knopf, A. Potosky, and R. Kaplan Patterns of care for the treatment of bladder cancer J Urol 169 2003 1697 1701
2. S. Holmang Follow-up of patients with noninvasive and superficially invasive bladder cancer Semin Urol Oncol 18 2000 273 279
3. S. Holmang, H. Hedelin, C. Anderstrom, E. Holmberg, C. Busch, and S.L. Johansson Recurrence and progression in low grade papillary urothelial tumors J Urol 162 1999 702 707
4. R.J. Sylvester, A.P. van der Meijden, and D.L. Lamm Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials J Urol 168 2002 1964 1970
5. H.W. Herr Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome J Urol 163 2000 60 61 [Discussion:61-62]
6. G.F. Riley, A.L. Potosky, J.D. Lubitz, and L.G. Kessler Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis Med Care 33 1995 828 841
7. Bladder Cancer Clinical Guideline Update Panel Guideline for the Management of Nonmuscle Invasive Bladder Cancer: (Stages Ta, T1, and Tis): 2007 Update 2007 Urological Association Education and Research, Inc Linthicum, MD, American
8. J.E. Montie, P.E. Clark, M.A. Eisenberger, R. El-Galley, R.E. Greenberg, H.W. Herr, G.R. Hudes, D.A. Kuban, T.M. Kuzel, and P.H. Lange Clinical practice guidelines in oncology: bladder cancer J Natl Compr Cancer Netw 7 2009 8 39 http://www.nccn.org/professionals/physician-gls/PDF/bladder.pdf
9. E. Solsona, I. Iborra, R. Dumont, J. Rubio-Briones, J. Casanova, and S. Almenar The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer J Urol 164 2000 685 689
10. M.C. Gulliford, A. Petruckevitch, and P.G. Burney Can efficiency of follow-up for superficial bladder cancer be increased? Ann R Coll Surg Engl 75 1993 57 61
11. B. Ali-El-Dein, O. Sarhan, A. Hinev, H.I. el Ibrahiem, A. Nabeeh, and M.A. Ghoneim Superficial bladder tumours: analysis of prognostic factors and construction of a predictive index BJU Int 92 2003 393 399
12. R.J. Sylvester, W. Oosterlinck, and A.P. van der Meijden A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials J Urol 171 2004 2186 2190 [Quiz:2435]
13. D.L. Lamm, B.A. Blumenstein, J.D. Crissman, J.E. Montie, J.E. Gottesman, B.A. Lowe, M.F. Sarosdy, R.D. Bohl, H.B. Grossman, and T.M. Beck Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group study J Urol 163 2000 1124 1129
14. F. Milln-Rodrguez, G. Chchile-Toniolo, J. Salvador-Bayarri, J. Palou, and J. Vicente-Rodrguez Multivariate analysis of the prognostic factors of primary superficial bladder cancer J Urol 163 2000 73 78
15. C.L. Amling Diagnosis and management of superficial bladder cancer Curr Probl Cancer 25 2001 219 278
16. S.A. Brassell, and A.M. Kamat Contemporary intravesical treatment options for urothelial carcinoma of the bladder J Natl Compr Cancer Netw 4 2006 1027 1036
17. D. Schrag, L.J. Hsieh, F. Rabbani, P.B. Bach, H. Herr, and C.B. Begg Adherence to surveillance among patients with superficial bladder cancer J Natl Cancer Inst 95 2003 588 597 (Pubitemid 36553505)
18. B. Sirovich, P.M. Gallagher, D.E. Wennberg, and E.S. Fisher Discretionary decision making by primary care physicians and the cost of U.S. Health care Health Aff Millwood 27 2008 813 823
19. E.S. Fisher, D.E. Wennberg, T.A. Stukel, D.J. Gottlieb, F.L. Lucas, and E.L. Pinder The implications of regional variations in Medicare spending. part 1: The content, quality, and accessibility of care Ann Intern Med 138 2003 273 287
20. E.S. Fisher, D.E. Wennberg, T.A. Stukel, D.J. Gottlieb, F.L. Lucas, and E.L. Pinder The implications of regional variations in Medicare spending. part 2: Health outcomes and satisfaction with care Ann Intern Med 138 2003 288 298
21. J.L. Warren, C.N. Klabunde, D. Schrag, P.B. Bach, and G.F. Riley Overview of the seer-Medicare data: content, research applications, and generalizability to the United States elderly population Med Care 40 Suppl 8 2002 IV-3-IV18
22. Surveillance, epidemiology, and end results (SEER) program http://www.seer.cancer.gov/ Accessed 1/24/09
23. O.H. Beahrs, D.E. Henson, and R.V.P. Hutter AJCC Manual for Staging of Cancer [3rd ed.] 1988 Lippincott Philadelphia, PA
24. J.E. Wennberg The Dartmouth Atlas of Health Care 1996 American Hospital Chicago
25. M.L. Brown, G.F. Riley, N. Schussler, and R. Etzioni Estimating health care costs related to cancer treatment from seer-Medicare data Med Care 40 Suppl 8 2002 IV-104 IV-117
26. C.N. Klabunde, A.L. Potosky, J.M. Legler, and J.L. Warren Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258 1267
27. A.V. Diez Roux, S.S. Merkin, D. Arnett, L. Chambless, M. Massing, F.J. Nieto, P. Sorlie, M. Szklo, H.A. Tyroler, and R.L. Watson Neighborhood of residence and incidence of coronary heart disease N Engl J Med 345 2001 99 106
28. K.S. Panageas, D. Schrag, E. Riedel, P.B. Bach, and C.B. Begg The effect of clustering of outcomes on the association of procedure volume and surgical outcomes Ann Intern Med 139 2003 658 665
29. D.Y. Lin Cox regression analysis of multivariate failure time data: the marginal approach Stat Med 13 1994 2233 2247
30. L.H. Olsen, and H.G. Genster Prolonging follow-up intervals for non-invasive bladder tumors: a randomized controlled trial Scand J Urol Nephrol Suppl 172 1995 33 36
31. E.S. Fisher, and H.G. Welch Avoiding the unintended consequences of growth in medical care: how might more be worse? J Am Med Assoc 281 1999 446 453
32. F.J. Fowler, P.M. Gallagher, D.L. Anthony, K. Larsen, and J.S. Skinner Relationship between regional per capita Medicare expenditures and patient perceptions of quality of care J Am Med Assoc 299 2008 2406 2412
33. S. Holmang, H. Hedelin, C. Anderstrom, and S.L. Johansson The relationship among multiple recurrences, progression and prognosis of patients with stages ta and T1 transitional cell cancer of the bladder followed for at least 20 years J Urol 153 1995 1823 1826 [Discussion:1826-1827]
34. L.A.G. Ries, D. Melbert, and M. Krapcho SEER cancer statistics Review 1975-2005 National Cancer Institute Bethesda, MD http://seer.cancer.gov/csr/ 1975-2005/ based on November 2007 SEER data submission, posted to the SEER web site, 2008.
35. J.M. Fitzpatrick, A.B. West, M.R. Butler, V. Lane, and J.D. O'Flynn Superficial bladder tumors (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection J Urol 135 1986 920 922
36. D.F. Penson, P.C. Albertsen, P.S. Nelson, M. Barry, and J.L. Stanford Determining cause of death in prostate cancer: are death certificates valid? J Natl Cancer Inst 93 2001 1822 1823
37. P.B. Bach, E. Guadagnoli, D. Schrag, N. Schussler, and J.L. Warren Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations Med Care 40 Suppl 8 2002 IV-19 IV-25